New York · 2025 Regular Session · Bill
S 9852: Relates to designated or rescheduled drugs
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 9852 is a bill introduced in the New York Senate on April 8, 2026. According to its official title, it concerns: Relates to designated or rescheduled drugs. Primary sponsor: Jessica Scarcella-Spanton (Democratic). It lists 3 additional sponsors. Most recent recorded action (April 8, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Provides that when a drug is designated or rescheduled by the federal government, it shall be deemed scheduled under NYS law automatically, without further action by the commissioner.
Sponsors
Sponsors by party (alphabetical): Democratic 3 · Democratic/Working Families 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Jessica Scarcella-Spanton | Primary sponsor | Democratic | Senate | 23 |
| John Liu | Co-sponsor | Democratic | Senate | 16 |
| Shelley Mayer | Co-sponsor | Democratic/Working Families | Senate | 37 |
| James Sanders | Co-sponsor | Democratic | Senate | 10 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH